Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2016 Mar-Apr;61(2):221-2.
doi: 10.4103/0019-5154.177769.

Low Prevalence of Anti-cyclic Citrullinated Peptide Antibodies in Japanese Patients with Pustulotic Arthro-osteitis

Takenobu Ohashi  1 , Tomoko Hiraiwa  1 , Toshiyuki Yamamoto  1
Affiliations

Low Prevalence of Anti-cyclic Citrullinated Peptide Antibodies in Japanese Patients with Pustulotic Arthro-osteitis

Takenobu Ohashi et al. Indian J Dermatol. 2016 Mar-Apr.
No abstract available

PubMed Disclaimer

References

    1. Yamamoto T. Pustulotic arthro-osteitis associated with palmoplantar pustulosis. J Dermatol. 2013;40:857–63. - PubMed
    1. Sonozaki H, Kawashima M, Hongo O, Yaoita H, Ikeno M, Matsuura M, et al. Incidence of arthro-osteitis in patients with pustulosis palmaris et plantaris. Ann Rheum Dis. 1981;40:554–7. - PMC - PubMed
    1. Payet J, Goulvestre C, Bialé L, Avouac J, Wipff J, Job-Deslandre C, et al. Anticyclic citrullinated peptide antibodies in rheumatoid and nonrheumatoid rheumatic disorders: Experience with 1162 patients. J Rheumatol. 2014;41:2395–402. - PubMed
    1. Pasquetti P, Morozzi G, Galeazzi M. Very low prevalence of anti-CCP antibodies in rheumatoid factor-negative psoriatic polyarthritis. Rheumatology (Oxford) 2009;48:315–6. - PubMed
    1. Shibata S, Tada Y, Komine M, Hattori N, Osame S, Kanda N, et al. Anti-cyclic citrullinated peptide antibodies and IL-23p19 in psoriatic arthritis. J Dermatol Sci. 2009;53:34–9. - PubMed

LinkOut - more resources